Daxdilimab
Product Specifications
CAS Number
2245966-28-1
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
Daxdilimab, an anti-ILT7 monoclonal antibody, targets the ILT7 cell surface molecule exclusive to pDC dendritic cells. It shows potential for treating acute lung injury (ALI) in COVID-19 infected patients, as indicated in research [1] [2].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS8100544-01 0.1 mg
Recombinant Anti-TLR2 Antibody (Biotin), Rabbit Monoclonal
Sign In for Pricing
View Details MBS8100544-02 5x 0.1 mg
Recombinant Anti-TLR2 Antibody (Biotin), Rabbit Monoclonal
Sign In for Pricing
View Details 
AFG-ELL-2081 > 1x 10^6 Cells / Vial
Immortalized Pig Tonsil Epithelial Cells
Sign In for Pricing
View Details TRV-0032920-01 20 µL
Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
Sign In for Pricing
View Details TRV-0032920-02 100 µL
Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
Sign In for Pricing
View Details TRV-0032920-03 200 µL
Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
Sign In for Pricing
View Details